Iveda Solutions, Inc. current report, 09 August 2022

Full document

Business Context and Reporting Period

This Form 8-K filing by Iveda Solutions, Inc. (IVDA) reports a material definitive agreement entered into on August 9, 2022. The company, incorporated in Nevada and headquartered in Mesa, Arizona, announced a private placement of securities that closed on August 11, 2022.

Key Financial Metrics and Transaction Details

  • Gross Proceeds: Approximately $5,000,000.
  • Securities Issued:
    • 1,100,000 shares of Common Stock at $1.52 per share.
    • 3,289,474 Common Warrants (exercise price: $1.40; term: 5.5 years).
    • 2,189,474 Pre-Funded Warrants (exercise price: $0.0001).
  • Placement Agent Fees: 7.0% of gross proceeds payable to Maxim Group LLC, plus reimbursement of expenses and legal fees.
  • Use of Proceeds: Working capital and general corporate purposes.

Material Changes and Agreements

The primary material change is the execution of a Securities Purchase Agreement and a Registration Rights Agreement. The Registration Rights Agreement requires the company to file a registration statement by August 24, 2022, and have it declared effective within 45 days of closing (or 75 days if a full SEC review occurs).

Liquidated Damages Provision: If the company fails to meet specific filing or effectiveness deadlines, it must pay investors 2.0% of their aggregate subscription amount as partial liquidated damages until the event is cured.

Outlook, Risks, and Contingencies

  • Regulatory Risk: The securities were sold under Regulation D exemptions and are not registered. Investors are restricted from reselling until a registration statement is effective or Rule 144 exemptions apply.
  • Dilution Risk: The issuance of common stock and warrants will increase the total share count, potentially diluting existing shareholders.
  • Contingency: The company's ability to avoid liquidated damages payments is contingent on timely SEC filing and effectiveness of the registration statement.

Investor Verification Checklist

  • Verify the final net proceeds after deducting the 7% placement fee and offering expenses.
  • Confirm the filing date and effectiveness status of the Registration Statement referenced in the Registration Rights Agreement.
  • Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for additional covenants or restrictions.
  • Assess the impact of the new share issuance and warrant exercises on the company's fully diluted share count.